Exploring medication adherence in Behçet’s disease following COVID-19: a mixed-methods study
Adherence to Behçet's Disease medication was generally good. Concerns participants had about medicines included sometimes not noticing the difference when they stopped taking medicines, fears about some medicines and concerns about side effects. However, based on their excellent understanding of the disease and trust in doctors, these concerns were balanced against the belief that medication was necessary to help their symptoms and maintain quality of life. To address concerns and ensure patients take medicines as prescribed, they need to be provided with up-to-date condition-specific advice.
Authors
- Emily Arden‐Close (ORCID: https://orcid.org/0000-0002-5954-2598)
- Danielle J. Guy (ORCID: https://orcid.org/0000-0003-2047-3473)
- Ala Yankouskaya (ORCID: https://orcid.org/0000-0003-0794-0989)
- Fay Sweeting (ORCID: https://orcid.org/0000-0002-0334-578X)
- Carmel Mallia
Institutions
- Bournemouth University (GB)
Publication Details
- Journal
- Orphanet Journal of Rare Diseases
- Published
- 2025-11-12
- DOI
- https://doi.org/10.1186/s13023-025-04090-8
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bournemouth University